| Recruitment status | Enrolling by invitation |
| Unique ID issued by UMIN | UMIN000022316 |
| Receipt No. | R000025709 |
| Scientific Title | The research for pathology and organ dysfunction of thyroid disease: a retrospective study |
| Date of disclosure of the study information | 2016/05/15 |
| Last modified on | 2019/05/18 (Ver. 3) |
| Basic information | ||
| Public title | The research for pathology and organ dysfunction of thyroid disease: a retrospective study | |
| Acronym | The research for pathology and organ dysfunction of thyroid disease | |
| Scientific Title | The research for pathology and organ dysfunction of thyroid disease: a retrospective study | |
| Scientific Title:Acronym | The research for pathology and organ dysfunction of thyroid disease | |
| Region |
|
|
| Condition | ||
| Condition | Thyroid disease | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | The pathology and oran dysfunction for thyroid disease including Basedow disease are not yet clarified. Patients with Basedow disease present with elevated IgG4 levels, and Basedow disease type IgG4 thyroiditis has been reported as a subtype of Basedow disease. However, many questions concerning the pathology of Basedow disease type IgG4 thyroiditis remain to be addressed, and its clinical features have not yet been established.
The aim of the present study was to determine the differences in clinical features and organ dysfunction of patients with Basedow disease and IgG4 thyroiditis. |
| Basic objectives2 | Others |
| Basic objectives -Others | elucidate the pathology |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | The aim of the was to determine the differences in clinical features of patients with Basedow disease and other thyroid disease. |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Thyroid disease and other endocrine disease who were managed at our hospital. | |||
| Key exclusion criteria | 1)patients with severe renal dysfunction including haemodialysis
2)patients with thyroid storm or myxedema coma 3)patients with pregnant or possibly pregnant women |
|||
| Target sample size | 500 | |||
| Research contact person | |||||||
| Last name of lead principal investigator |
|
||||||
| Organization | University of Occupational and Environmental Health | ||||||
| Division name | First Department of Internal Medicine, School of Medicine | ||||||
| Zip code | 807-8555 | ||||||
| Address | 1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu | ||||||
| TEL | 093-603-1611 | ||||||
| tanaka@med.uoeh-u.ac.jp | |||||||
| Public contact | |||||||
| 1st name of contact person |
|
||||||
| Organization | University of Occupational and Environmental Health | ||||||
| Division name | First Department of Internal Medicine, School of Medicine | ||||||
| Zip code | 807-8555 | ||||||
| Address | 1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu | ||||||
| TEL | 093-603-1611 | ||||||
| Homepage URL | |||||||
| torimoto@med.uoeh-u.ac.jp | |||||||
| Sponsor | |
| Institute | University of Occupational and Environmental Health, Japan, First Department of Internal Medicine, School of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | University of Occupational and Environmental Health, Japan, First Department of Internal Medicine, School of Medicine |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | University of Occupational and Environmental Health |
| Address | 1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu |
| Tel | 0936031611 |
| sunday@pub.uoeh-u.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Enrolling by invitation | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | The pathology and oran dysfunction for thyroid disease including Basedow disease are not yet clarified. Patients with Basedow disease present with elevated IgG4 levels, and Basedow disease type IgG4 thyroiditis has been reported as a subtype of Basedow disease. However, many questions concerning the pathology of Basedow disease type IgG4 thyroiditis remain to be addressed, and its clinical features have not yet been established.
The aim of the present study was to determine the differences in clinical features and organ dysfunction of patients with Basedow disease and IgG4 thyroiditis. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000025709 |